Celera Closes $195M Berkeley HeartLab Acquisition | GenomeWeb
NEW YORK (GenomeWeb News) — Celera said today it has closed its acquisition of Berkeley HeartLab for around $195 million in cash.
 
Celera said the acquisition, originally announced in early September, will begin to bring in accretive earnings in the second half of fiscal 2008.
  
Celera president Kathy Ordonez said the company was attracted to BHL for its existing products and for its potential to develop new predictive molecular diagnostics for cardiovascular disease.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.